《亚洲股市》日经急弹2.1% 印度及菲股续跌0.7%
美股期货全面微吐0.1%。亚太区主要股市今天普遍跟随昨晚欧美市场造好,尤其是获标普确认国家主权信贷评级为「A+/A-1」及评级展望稳定的日经扭两连挫,最高见29,110,现造29,098,回升589点或2.1%;台湾加权指数继昨天整固後,今天再创纪录高,最高见17,428遇阻,现造17,260,仅回升0.3%。
泰国、澳洲、新西兰、南韩、马来西亚及新加坡股市升0.2%-0.7%,後者最强报3,177。
港股扭转昨天急吐逾500点弱势,今早反覆回升132点或近0.5%,半日收28,754。深成反覆续升0.5%半日收14,221;但沪指半日收3,471,反覆微跌不足2点。
印度疫情急剧恶化,政府下月起容许所有18岁以上国民接种疫苗。印度孟买指数假後复市延续过去两连跌弱势,今早曾再跌1%低见47,204,现造47,376,续跌0.7%。当地疫情严峻的菲股续跌0.7%报6,395。越南假後复市由纪录高位回吐0.4%报1,263。当地疫情反弹的印尼连续第四天反覆受压,现造5,988,反覆跌5点。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.